Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Apr 22, 2015
Dublin, Ireland – April 22, 2015 – On April 16, Perrigo Company plc (NYSE: PRGO; TASE) announced it had received final U.S. Food and Drug Administration approval and had launched the...
-
Apr 21, 2015Company Provides Guidance for Calendar Year 2015 and Three-Year Organic Net Sales Growth Rate Goals
Third Quarter FY 2015 Highlights: Delivered record fiscal third quarter net sales of $1.05 billion. Excluding the effect of the pre-closing debt and equity issuances related to the Omega Pharma...
-
Apr 21, 2015This is an announcement falling under Rule 2.4 of Irish Takeover Panel Act, 1997, Takeover Rules, 2013 (the "Irish Takeover Rules").
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that its Board of Directors has unanimously rejected the unsolicited Proposal (the "Proposal") from Mylan NV ("Mylan") (NASDAQ:...
-
Apr 20, 2015
Thousands of law enforcement K-9s put their lives on the line to protect America on a daily basis. They are usually the first officer to enter a dangerous situation, and help track and neutralize...
-
Apr 16, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final Federal Drug Administration approval for Triamcinolone Acetonide Topical Aerosol, the generic version of Sun...